Navigation Links
Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting
Date:4/14/2008

SAN FRANCISCO, April 14 /PRNewswire-FirstCall/ -- Positive preclinical data was presented by Nektar Therapeutics (Nasdaq: NKTR) this week for its lead oncolytic candidate, NKTR-102 (PEG-irinotecan), which demonstrated enhanced anti-tumor activity in a mouse xenograft model of colorectal cancer when co-administered with bevacizumab. Presented at the American Association for Cancer Research (AACR) Annual Meeting 2008 in San Diego, California, the data also featured the enhanced pharmacokinetic profile and tolerability of NKTR-102, as compared to irinotecan in animal models.

NKTR-102 is a PEGylated form of irinotecan developed using Nektar's innovative small molecule PEGylation technology platform. NKTR-102 is currently in a Phase 2 development program to evaluate its safety and efficacy as a second-line colorectal cancer therapy in combination with cetuximab. Nektar had previously announced its intention to expand the NKTR-102 Phase 2 clinical development program later this year with additional indications.

"NKTR-102 is demonstrating important promise as a solid tumor treatment that could be used in a number of critical cancer care regimens," said Tim Riley, Ph.D., Vice President of PEGylation Research at Nektar. "These data reinforce our confidence in the potential of our small molecule PEGylation technology platform to improve the therapeutic potential of oncolytics that are widely used to treat cancer. We look forward to presenting new data from our clinical trials at additional major oncology conferences this year."

In the preclinical studies presented at AACR, NKTR-102 was co-administered with bevacizumab to evaluate the effects of combination therapy. The combination therapy had an additive effect, inhibiting tumo
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
2. BiPar Announces Preclinical Data Demonstrating Anti-Tumor Activity With BSI-401, Its Second-Generation PARP Inhibitor
3. Human Genome Sciences Presents New Data Showing Anti-Tumor Activity And Safety Of Trail Receptor Antibodies In Combination With Chemotherapy
4. Updated Phase 1 Data for Exelixis XL184 Demonstrate Pharmacodynamic and Clinical Anti-Tumor Activity
5. Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models
6. Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months
7. Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007
8. Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722
9. Rigels R788 Shows Preclinical Activity in Type 1 Diabetes Model
10. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
11. Evotecs EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity During the Performance of Cognitive Tasks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... GeoInvesting.com, we have been tracking Tianyin Pharmaceuticals (NYSE Amex: ... hang up had been with the potential dilution from ... income guidance of $11.3 million represents a 43.0% increase ... million, the increase in shares poses some uncertainty regarding ... the share price and the Treasury method of accounting ...
(Date:12/14/2009)... 14 According to Millennium Research Group ... intelligence, increased use of safety devices for small-bore ... a key driver of the enteral feeding device ... new US and European Markets for Enteral ... giving set segment will experience the greatest impact ...
(Date:12/14/2009)... COLLINS, Colo., Dec. 14 Manchester Pharmaceuticals, ... mg (chenodiol tablets). On October 22, 2009, ... Chenodal, an important therapy for patients suffering from ... risk due to disease or advanced age. ,, ... patients exclusively through Centric Health Resources ("Centric"), a ...
Breaking Medicine Technology:GeoInvesting.com Offers Insight Into Two Growing Chinese Pharmaceutical Firms 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3Manchester Announces Availability of Chenodal(TM) 2Legislation Will Expand Access to Life Saving Laboratory Tests 48470 1Legislation Will Expand Access to Life Saving Laboratory Tests 48470 2Beetle shell inspires brilliant white paper 8787 1Beetle shell inspires brilliant white paper 8787 2Beetle shell inspires brilliant white paper 8787 3Helping Dad Stay Independent 3A The Best Fathers Day Gift for an Aging Parent A Checklist from Dr Dan Tobin Founder and CEO of Care Support of Ame 48467 1Helping Dad Stay Independent 3A The Best Fathers Day Gift for an Aging Parent A Checklist from Dr Dan Tobin Founder and CEO of Care Support of Ame 48467 2Helping Dad Stay Independent 3A The Best Fathers Day Gift for an Aging Parent A Checklist from Dr Dan Tobin Founder and CEO of Care Support of Ame 48467 3Helping Dad Stay Independent 3A The Best Fathers Day Gift for an Aging Parent A Checklist from Dr Dan Tobin Founder and CEO of Care Support of Ame 48467 4
(Date:12/14/2009)... and smoking, but concerns about prescription abuse, , ... teenagers are using methamphetamine, but reductions in marijuana ... remains high, U.S. health officials report. , In ... the hallucinogenic salvia leaf and the prescription medication ... hyperactivity disorder (ADHD), appear to be gaining a ...
(Date:12/14/2009)... Conkling of Moraga, CA, retired Senior Vice President of ... Chair of the Board of Trustees of the American Foundation ... to which Helen Keller devoted more than 40 years ... in San Francisco, Dallas, Atlanta, Washington, ... possibilities for people with vision loss. ,, "As we ...
(Date:12/14/2009)... asked to approve naming the women,s hospital -- located ... complex -- after Ted and Jane Von Voigtlander ... University of Michigan Health System has received a $15 ... Foundation, the largest gift ever made to the Health ... of a new women,s hospital. ,, The gift is ...
(Date:12/14/2009)... published in the December issue of Mayo Clinic ... disorder myelofibrosis. This retrospective study is the largest ever ... Myelofibrosis is a serious disorder that disrupts the body,s ... scarring in the bone marrow, leading to severe anemia, ... , "In the past 20 years, management of ...
(Date:12/14/2009)... appears to reduce liver inflammation in cancer patients, ... -- A medicinal herb, milk thistle, appears to ... study finds. , Chemo drugs often cause liver ... or suspend treatment until the inflammation subsides. These ... the researchers said. , "We found that milk ...
Breaking Medicine News(10 mins):Health News:Marijuana Use No Longer Dropping Among U.S. Teens 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 4Health News:The American Foundation for the Blind Welcomes New Board Chair, Concetta F. Conkling 2Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 2Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 3Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 4Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 5Health News:Herb May Counter Liver Damage From Chemo 2Health News:Herb May Counter Liver Damage From Chemo 3
... ENGLEWOOD, N.J., March 10 The Institute for ... (formerly the NJ Institute for Bloodless Medicine and ... its 15th anniversary this year. The new name ... of patient blood and blood products to improve ...
... freezing tumor rather than removing entire gland , , TUESDAY, ... prostate cancer that destroys only the part of the ... than surgery or radiation therapy, a new study finds. ... invasive procedure that freezes part of the prostate. The ...
... Cole,s Personal Experience Gives Unique Insight in IndustrySACRAMENTO, ... rehab specialist with 15 years of experience, has ... one of the nation,s fastest growing accredited complex ... Professional (ATP) in Sacramento, Calif., for ASM ...
... side effects of surgeryNEW YORK, March 10 See ... http://inr.mediaseed.tv/SIR_36322/ PROSTATE CANCER A minimally invasive ... prostate tumors -- proves as effective as surgery ... urinary dysfunction. The so-called "male lumpectomy" can be ...
... Four Seasons and seven additional hotels join effort to ... hotel owner, Strategic Hotels, today announced that it will ... water campaign known as the Tap Project . ... initiative helps UNICEF provide clean water to children around ...
... small group coverageWASHINGTON, March 10 Affordable coverage ... priority as the nation pursues health care reform, ... America,s Health Insurance Plans (AHIP) said today at ... pursue creative, private market solutions to what has ...
Other Medicine News:Health News:Englewood Hospital Marks 15 Years of Leadership in Improving Patient Outcomes Through Bloodless Medicine and Surgery 2Health News:Englewood Hospital Marks 15 Years of Leadership in Improving Patient Outcomes Through Bloodless Medicine and Surgery 3Health News:'Male Lumpectomy' May Help Some With Prostate Cancer 2Health News:'Male Lumpectomy' May Help Some With Prostate Cancer 3Health News:Veteran Rehab Specialist, Donna Cole, Joins Fast-Growing Alliance Seating & Mobility in California 2Health News:VIDEO from Medialink and the Society of Interventional Radiology: Prostate and Kidney Cancer - New Life-Changing Developments 2Health News:Tap Project Partners With Strategic Hotels for 2009 UNICEF Clean Water Campaign 2Health News:Tap Project Partners With Strategic Hotels for 2009 UNICEF Clean Water Campaign 3Health News:NFIB and AHIP Urge Focus on Affordable Health Care for Small Businesses 2Health News:NFIB and AHIP Urge Focus on Affordable Health Care for Small Businesses 3Health News:NFIB and AHIP Urge Focus on Affordable Health Care for Small Businesses 4
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
Paraffin Block Storage System...
The Modular Storage Drawers provide permanent storage and identification of up to 165 embedding rings or 250 cassettes per drawer....
Improving on the technology that the world has come to expect from the original SHUR/Mark® Cassette and Slide Labelers, SHUR/Mark® PLUS offers many added enhancements....
Medicine Products: